State Street
WHWK

State Street’s Whitehawk Therapeutics WHWK Stock Holding History

State Street’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$553K Buy
160,382
+14,845
+10% +$46.5K ﹤0.01% 3629
2025
Q4 		$352K Buy
145,537
+76,800
+112% +$176K ﹤0.01% 3772
2025
Q3 		$131K Hold
68,737
– – ﹤0.01% 4004
2025
Q2 		$129K Hold
68,737
– – ﹤0.01% 3930
2025
Q1 		$122K Hold
68,737
– – ﹤0.01% 3927
2024
Q4 		$217K Hold
68,737
– – ﹤0.01% 3834
2024
Q3 		$142K Hold
68,737
– – ﹤0.01% 3903
2024
Q2 		$100K Sell
68,737
-306,410
-82% -$568K ﹤0.01% 4014
2024
Q1 		$878K Buy
375,147
+60,238
+19% +$116K ﹤0.01% 3505
2023
Q4 		$636K Buy
314,909
+18,540
+6% +$77.8K ﹤0.01% 3588
2023
Q3 		$1.43M Sell
296,369
-1,654
-0.6% -$9.62K ﹤0.01% 3439
2023
Q2 		$2.04M Buy
298,023
+31,678
+12% +$246K ﹤0.01% 3407
2023
Q1 		$1.93M Buy
266,345
+301
+0.1% +$3.22K ﹤0.01% 3353
2022
Q4 		$3.41M Buy
266,044
+15,984
+6% +$209K ﹤0.01% 3207
2022
Q3 		$3.53M Sell
250,060
-285,554
-53% -$3.75M ﹤0.01% 3225
2022
Q2 		$6.6M Buy
535,614
+36
+0% +$535 ﹤0.01% 2956
2022
Q1 		$9.09M Buy
535,578
+224,178
+72% +$4.3M ﹤0.01% 2874
2021
Q4 		$7.52M Buy
+311,400
New +$7.82M ﹤0.01% 3055
2021
Q3 		– Sell
-8,523
Closed -$216K – 4710
2021
Q2 		$216K Buy
+8,523
New +$195K ﹤0.01% 4190

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

State Street's WHWK Position: Q1 2026 in Review

State Street increased its Whitehawk Therapeutics (WHWK) stake by 10% in Q1 2026, buying an estimated $46.5K and bringing the position to 160,382 shares worth $553K. The position accounts for ﹤0.01% of the portfolio, ranked #3629.

State Street first reported a position in WHWK in Q2 2021 and has held it in 19 quarters since. The position peaked at $9.09M in Q1 2022. 62 funds tracked by Wall St. Rank hold WHWK as of Q1 2026.

  • State Street held 160,382 shares of Whitehawk Therapeutics worth $553K as of Q1 2026.
  • State Street bought 14,845 Whitehawk Therapeutics shares in Q1 2026, an estimated $46.5K.
  • Whitehawk Therapeutics made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3629 holding.
  • State Street first reported a position in Whitehawk Therapeutics in Q2 2021 and has held it in 19 quarters since.
  • State Street's Whitehawk Therapeutics position peaked at $9.09M in Q1 2022.
  • 62 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.